Solid pharmaceutical formulation for a pipeazine urea derivative

Details for Australian Patent Application No. 2002333896 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Tack, Johannes; Volkel, Christoph; Kranz, Heiko; Wiesinger, Herbert; Lipp, Ralph

Agent Davies Collison Cave

Pub. Number AU-B-2002333896

PCT Number PCT/EP02/11229

PCT Pub. Number WO2003/035037

Priority 101 52 351.3 18.10.01 DE

Filing date 7 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 26 July 2007

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 101 52 351.3 18.10.01 DE

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002333896

5 August 2004 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Jul 2004

26 July 2007 Application Accepted

  Published as AU-B-2002333896

2 August 2007 Change of Name(s) of Applicant(s), Section 104

  Schering AG The name of the applicant has been changed to Bayer Schering Pharma Aktiengesellschaft 2003

29 November 2007 Standard Patent Sealed

21 February 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Solid pharmaceutical formulation for a piperazine urea derivative

30 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002333897-NEW DRY AND AQUEOUS EPINASTINE-SYRUP-FORMULATION

2002333895-Methods for preventing and treating bone loss with steroid compounds